Definitions

Sorry, no definitions found. Check out and contribute to the discussion of this word!

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word tiuxetan.

Examples

  • The new drugs include rituximab (sold as Rituxan), with four boxed warnings, and ibritumomab tiuxetan (Zevalin), with two boxed warnings, among others.

    Yahoo! News: Business - Opinion 2010

  • The new drugs include rituximab (sold as Rituxan), with four boxed warnings, and ibritumomab tiuxetan (Zevalin), with two boxed warnings, among others.

    Yahoo! News: Business - Opinion 2010

  • ZEVALIN (ibritumomab tiuxetan) is indicated for the treatment of patients with previously untreated follicular non-Hodgkin's Lymphoma (NHL), who achieve a partial or complete response to first-line chemotherapy.

    Business Wire Travel News 2010

  • ZEVALIN (ibritumomab tiuxetan) is indicated for the treatment of patients with previously untreated follicular non-Hodgkin's Lymphoma (NHL), who achieve a partial or complete response to first-line chemotherapy.

    The Earth Times Online Newspaper 2010

  • The new drugs include rituximab (sold as Rituxan), with four boxed warnings, and ibritumomab tiuxetan (Zevalin), with two boxed warnings, among others.

    msnbc.com: Top msnbc.com headlines 2010

  • The new drugs include rituximab (sold as Rituxan), with four boxed warnings, and ibritumomab tiuxetan (Zevalin), with two boxed warnings, among others.

    Yahoo! News: Business - Opinion 2010

  • The new drugs include rituximab (sold as Rituxan), with four boxed warnings, and ibritumomab tiuxetan (Zevalin), with two boxed warnings, among others.

    msnbc.com: Top msnbc.com headlines 2010

  • ZEVALIN (ibritumomab tiuxetan) is a CD20-directed radiotherapeutic antibody administered as part of the ZEVALIN therapeutic regimen.

    BioSpace.com Featured News and Stories 2009

  • -- (BUSINESS WIRE) -- Spectrum Pharmaceuticals (NasdaqGM: SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced ZEVALIN® (ibritumomab tiuxetan), a CD20-directed radiotherapeutic antibody, received approval from the U.S.

    BioSpace.com Featured News and Stories 2009

  • Data from clinical trials suggest that radio-immunotherapy (RIT) consolidation therapy is an important treatment approach for patients with follicular lympho ma (FL), with striking phase 3 results recently published for 90Y-ibritumomab tiuxetan

    SeekingAlpha.com: Home Page 2009

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.